The Marvin & Concetta Greenberg Pancreatic Cancer Institute is a hub of pioneering research and clinical excellence. Integrating Basic Biology, Clinical Medicine, and Population Science, the institute fosters collaboration among experts to drive innovation. From bench to bedside and back, discoveries are translated into tangible patient benefits, enhancing early detection and treatment options. Since its establishment in 2017, the dedicated multidisciplinary team of researchers and clinicians has pursued breakthroughs in understanding the tumor micro- and macro-environments and their systemic impact on pancreatic cancer onset, progression, and response to treatments. The team's mission aims to improve outcomes and survival rates for pancreatic cancer patients. The leaders of the Greenberg Pancreatic Cancer Institute are Igor Astsaturov, MD, PhD, Edna (Eti) Cukierman, PhD, and Sanjay S. Reddy, MD, FACS.